Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt | ($415.6M) | ($369.3M) | ($633.7M) | ($1,174.3M) | ($1,471.2M) | ($2,196.1M) | ($2,475.0M) | ($2,895.3M) | ($2,751.2M) | ($2,258.7M) | ($2,466.0M) | ($2,821.5M) | ($2,894.5M) | ($2,760.7M) | ($2,322.9M) | ($1,645.5M) | ($393.3M) | $1,400.0M | $317.1M | ($477.2M) |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, Novo Nordisk A/S's last 12-month Net Debt is ($2,672.6M), based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, Novo Nordisk A/S's Net Debt growth was (31.5%). The average annual Net Debt growth rates for Novo Nordisk A/S have been N/A over the past three years, 5.0% over the past five years.
Over the last year, Novo Nordisk A/S's Net Debt growth was (31.5%), which is lower than industry growth of (0.1%). It indicates that Novo Nordisk A/S's Net Debt growth is Good.